The Venture Collective

The Venture Collective is a venture capital investment firm founded in 2019, with headquarters in New York City and a presence in London. The firm focuses on early-stage investments, particularly at the Pre-Seed and Seed stages, while maintaining reserves for follow-on investments through Series A. It targets highly defensible and fast-growing companies across various sectors, including agriculture technology, artificial intelligence, clean technology, digital health, and more. Committed to fostering diversity, The Venture Collective actively seeks out diverse founding teams, believing that this approach enhances both business success and financial returns. The firm operates as an impact investment firm and is a Registered Investment Adviser, emphasizing the potential for its portfolio companies to address significant global challenges.

Ruby Anaya

Venture Partner

Joe Brown

Venture Partner

Madelaine Czufin

Venture Partner

Caitlin Herling

Principal

Catherine Hernandez

General Partner

Oliver Horsnall

Vice President, Clients

Gina Kirch

Founding Partner

Stephanie Sarelakos

Principal

Kevin Shannon

Principal

Seanna Thompson

Venture Partner

46 past transactions

SimpliFed

Seed Round in 2025
SimpliFed is a telehealth company founded in 2020 that focuses on providing virtual breastfeeding support to new and expectant parents. It addresses the challenges faced by these individuals, such as sleep deprivation and concerns about infant nutrition. SimpliFed offers a maternal care platform that delivers virtual-first care throughout the peri and postnatal periods. The company specializes in lactation and baby feeding support, as well as monitoring high-risk conditions like hypertension and gestational diabetes. By engaging with patients early, SimpliFed’s care navigators facilitate a comprehensive maternal care experience, allowing parents to receive timely answers to their questions about infant feeding through secure online and video connections.

Concert Bio

Funding Round in 2024
Concert Bio is a technology company that assists businesses in enhancing their microbial communities' productivity through its proprietary full-stack platform. This platform integrates monitoring, analytics, and intervention strategies to manipulate microbiomes, empowering clients to optimize these communities for improved performance.

Infogrid

Funding Round in 2024
Infogrid is an AI technology company that specializes in automating facilities management to create smarter buildings. By integrating Internet of Things (IoT) sensors with artificial intelligence, Infogrid streamlines and enhances building management processes, resulting in significant savings in time, costs, and environmental impact while also improving safety. The sensors used are compact, unobtrusive, and cost-effective, allowing for quick implementation. Infogrid's proprietary algorithms and machine learning capabilities convert collected data into actionable insights that promote energy efficiency and cost reduction, seamlessly integrating with existing systems. With its comprehensive platform, Infogrid enables clients to develop healthier, more sustainable, and profitable environments for their real estate and facilities teams.

Wonderbelly

Series A in 2024
Wonderbelly is a company that specializes in digestive health products, focusing on the development and marketing of antacid remedies designed to alleviate heartburn and acid reflux symptoms. Its product offerings include non-genetically modified and vegan drugs made from a blend of ingredients such as calcium carbonate, vegetable cellulose, vegetable stearate, maize starch, sucrose, and natural flavors. By utilizing these carefully selected components, Wonderbelly aims to provide effective solutions for individuals experiencing gastroenterological issues like acid indigestion and upset stomach. The company's commitment to health and wellness is reflected in its product formulation, catering to consumers seeking natural and effective relief options.

Orbillion Bio

Venture Round in 2024
Orbillion Bio, Inc. is a food-tech company based in Fremont, California, focused on developing cultured meat products derived from heritage cattle breeds. Founded in 2019, the company utilizes small tissue samples from high-quality heritage animals to produce premium cell-based meat products. Orbillion Bio aims to harness the potential of cell-cultured meat to provide delicious and nutritious food that is sustainable and accessible. By sourcing heritage cell lines directly from farmers, the company emphasizes a commitment to quality and sustainability in its production processes.

Unnatural Products

Series A in 2023
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, focused on drug discovery through innovative technology. Founded in 2016, the company specializes in designing and developing a platform that utilizes artificial intelligence and computational biology techniques to create macrocyclic peptides. These peptides target intracellular protein interactions, addressing drug targets that are typically considered undruggable. By harnessing machine learning to optimize chemical synthesis, Unnatural Products aims to accelerate the drug discovery process, offering potential therapeutic strategies for a wide range of medical conditions. Through its unique approach, the company seeks to pioneer new treatments where traditional methods have fallen short.

Arogga

Seed Round in 2023
Arogga is a pioneering healthcare application in Bangladesh that facilitates the delivery of prescription and healthcare services directly to users' doorsteps. The platform allows users to easily upload their prescriptions, ensuring the prompt delivery of medicines and healthcare products. Arogga offers a comprehensive selection of items, including prescription medications, over-the-counter drugs, vitamins, dietary supplements, herbal products, and beauty care items. By connecting users with pharmacies, doctors, and laboratories, Arogga aims to streamline the healthcare experience and make purchasing medications more accessible and affordable. With plans for future service expansions, Arogga is positioned to become the leading healthcare platform in Bangladesh.

Orbem

Series A in 2023
Orbem is a company that specializes in a sensor-based artificial intelligence breeding monitoring system designed to transform food production systems. Utilizing advanced magnetic resonance imaging, Orbem's technology automatically analyzes and classifies biological samples, significantly enhancing food production methods to address the demands of a growing global population. The company’s solutions enable customers to optimize their processing lines, leading to increased cost efficiency and the creation of high-quality products, while also opening new revenue streams. By focusing on sustainability, Orbem aims to revolutionize the way food is produced, making it more efficient and environmentally friendly.

Lopay

Seed Round in 2023
Lopay is a fintech company that develops a platform designed to empower small businesses by providing them with payment tools. The platform allows users to accept payments through various means, including mobile devices, payment stickers, and card readers. By focusing on independent and small businesses, Lopay aims to facilitate faster and more cost-effective cashless transactions, ensuring that users have instant access to the funds they earn. Through its innovative payment applications, Lopay seeks to enhance control and flexibility for its clientele, ultimately streamlining their financial interactions.

Caraway

Series A in 2023
Caraway is a digital healthcare company focused on providing integrated mental, reproductive, and physical healthcare services specifically for college women. Designed with input from students, Caraway delivers a personalized and equitable care solution that addresses the unique needs and concerns of women during a crucial developmental period. The platform emphasizes accessible and compassionate healthcare, recognizing the growing demand for mental health resources and the persistent inequities in women's health. By offering trusted and holistic care, Caraway empowers college students to effectively manage their health in a complex and often challenging healthcare landscape.

MDisrupt

Seed Round in 2023
MDisrupt is a leading health expert marketplace specifically designed for the life sciences and healthtech sectors. The company connects organizations with thoroughly vetted experts in clinical, commercial, regulatory, and reimbursement fields through an AI-powered platform. This facilitates easy scheduling and engagement for consultations, advisory roles, and full-time positions. MDisrupt has assisted over 100 clients, ranging from startups to large enterprises, in efficiently building, commercializing, and scaling their healthcare products. Additionally, the platform supports clinically crowdsourced data generation, empowering patients and providers to make informed healthcare decisions. By streamlining access to expertise, MDisrupt aims to accelerate the development and market introduction of impactful health products.

Infogrid

Series B in 2023
Infogrid is an AI technology company that specializes in automating facilities management to create smarter buildings. By integrating Internet of Things (IoT) sensors with artificial intelligence, Infogrid streamlines and enhances building management processes, resulting in significant savings in time, costs, and environmental impact while also improving safety. The sensors used are compact, unobtrusive, and cost-effective, allowing for quick implementation. Infogrid's proprietary algorithms and machine learning capabilities convert collected data into actionable insights that promote energy efficiency and cost reduction, seamlessly integrating with existing systems. With its comprehensive platform, Infogrid enables clients to develop healthier, more sustainable, and profitable environments for their real estate and facilities teams.

Pragma Bio

Series A in 2023
Pragma Bio is a biotechnology company that focuses on developing microbiome-based therapeutics for cancer and autoimmune diseases. Founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti, the company utilizes proprietary genomic sequencing, artificial intelligence, and synthetic biology techniques to discover biomarkers and therapeutics for complex immunologic disorders. Pragma Bio's platform aggregates both public and private data to create a comprehensive microbiome database, enhancing the ability to identify connections between diverse biological data. This approach not only aids in the discovery of novel biomarkers for patient risk stratification and clinical outcome prediction but also enables the identification of small molecules derived from human-associated bacteria. By leveraging real-world data and advanced analytical processes, Pragma Bio aims to streamline drug discovery and deliver innovative medicines more efficiently and cost-effectively, particularly in relation to the gut-immune axis.

MDisrupt

Convertible Note in 2023
MDisrupt is a leading health expert marketplace specifically designed for the life sciences and healthtech sectors. The company connects organizations with thoroughly vetted experts in clinical, commercial, regulatory, and reimbursement fields through an AI-powered platform. This facilitates easy scheduling and engagement for consultations, advisory roles, and full-time positions. MDisrupt has assisted over 100 clients, ranging from startups to large enterprises, in efficiently building, commercializing, and scaling their healthcare products. Additionally, the platform supports clinically crowdsourced data generation, empowering patients and providers to make informed healthcare decisions. By streamlining access to expertise, MDisrupt aims to accelerate the development and market introduction of impactful health products.

Gravitics

Seed Round in 2022
Gravitics, Inc. specializes in the design and manufacturing of large space structures, including orbital carriers, cargo logistics spacecraft, and space station modules. The company is focused on developing aerospace station technology that serves as the foundation for human life in space. Utilizing next-generation hardware, Gravitics' innovations facilitate shipyard-style fabrication within the aerospace sector, providing clients with versatile interfacing options and robust space armor. Through its advancements, Gravitics aims to redefine space superiority and promote commercial development in Earth orbit and beyond.

coding.bio

Seed Round in 2022
Coding.bio provides AI for cell therapies through automation and computation. They work at the intersection of computation, synthetic biology, and cell therapy. They also provide curative therapeutics for patients.

Ruby Bio

Seed Round in 2022
Ruby Bio is a biotechnology company specializing in biosynthesis. It employs naturally occurring yeast as a production facility to transform readily available sugars into valuable, biodegradable, and non-toxic complex molecules. This process enables Ruby Bio's clients to create sustainable personal care, home care, food, and beverage products.

Heading Health

Pre Seed Round in 2022
Heading Health is a technology-enabled mental health platform dedicated to enhancing access to affordable care. The company provides personalized treatment solutions that utilize evidence-based therapeutics and advanced technologies such as transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. By leveraging these tools, Heading Health aims to deliver effective and convenient mental health services, helping patients achieve meaningful outcomes and improved well-being.

Stack

Seed Round in 2022
Stack is the gamified crypto investment platform specifically built for Gen-Z.

Violet

Seed Round in 2022
Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone.

Concert Bio

Pre Seed Round in 2022
Concert Bio is a technology company that assists businesses in enhancing their microbial communities' productivity through its proprietary full-stack platform. This platform integrates monitoring, analytics, and intervention strategies to manipulate microbiomes, empowering clients to optimize these communities for improved performance.

Wonderbelly

Seed Round in 2022
Wonderbelly is a company that specializes in digestive health products, focusing on the development and marketing of antacid remedies designed to alleviate heartburn and acid reflux symptoms. Its product offerings include non-genetically modified and vegan drugs made from a blend of ingredients such as calcium carbonate, vegetable cellulose, vegetable stearate, maize starch, sucrose, and natural flavors. By utilizing these carefully selected components, Wonderbelly aims to provide effective solutions for individuals experiencing gastroenterological issues like acid indigestion and upset stomach. The company's commitment to health and wellness is reflected in its product formulation, catering to consumers seeking natural and effective relief options.

Endpoint Health

Series A in 2022
Endpoint Health, Inc. is a precision immunology company focused on researching and developing therapies that enhance outcomes for patients with critical and immune-driven illnesses, including sepsis, acute respiratory distress syndrome, and COVID-19. Founded in 2018 and headquartered in Palo Alto, California, with additional offices in Detroit, Livonia, and Chicago, the company aims to overcome the limitations of traditional drug development by creating precision therapies tailored to individual patient needs. Utilizing its proprietary AI-powered platform, OMNAI, Endpoint Health identifies and matches high-potential therapies to patients most likely to benefit, ensuring personalized treatment that significantly improves health outcomes. The company is committed to delivering innovative solutions that address the complexities of autoimmune and inflammatory conditions.

SimpliFed

Seed Round in 2022
SimpliFed is a telehealth company founded in 2020 that focuses on providing virtual breastfeeding support to new and expectant parents. It addresses the challenges faced by these individuals, such as sleep deprivation and concerns about infant nutrition. SimpliFed offers a maternal care platform that delivers virtual-first care throughout the peri and postnatal periods. The company specializes in lactation and baby feeding support, as well as monitoring high-risk conditions like hypertension and gestational diabetes. By engaging with patients early, SimpliFed’s care navigators facilitate a comprehensive maternal care experience, allowing parents to receive timely answers to their questions about infant feeding through secure online and video connections.

Knoma

Venture Round in 2022
Knoma Ltd is a London-based company that operates an online platform designed to facilitate access to educational loans for a variety of courses, including cybersecurity, coding, and software development. Founded in 2018 and previously known as Higgler Europe Ltd, Knoma aims to address the digital skills gap in the evolving global economy. The platform allows users to finance their education by spreading course costs over flexible monthly payments, with loans available up to £10,000, all offered without interest or fees. By partnering with leading coding and tech schools, Knoma emphasizes the importance of lifelong learning and aims to make education more accessible, thereby helping individuals enhance their career prospects and adapt to the demands of a rapidly changing job market.

Ellevest

Series B in 2022
Ellevest, Inc. is an investment management firm focused on providing financial services tailored specifically for women. Founded in 2014 and based in New York City, Ellevest aims to empower female investors by offering a digital platform that incorporates proprietary algorithms to develop customized investment plans. The firm employs fundamental analysis and a top-down approach to create client-focused portfolios that span various global asset classes. Ellevest's user-friendly interface reflects its commitment to engaging women in a thoughtful and accessible investing experience, allowing clients to prioritize their financial goals and make informed decisions regarding their investments.

Everna

Seed Round in 2022
Everna Limited is a biotechnology company based in London, United Kingdom, focused on developing innovative therapeutics to combat age-related diseases. Incorporated in 2016, Everna specializes in creating drugs that target key cellular functions affected by aging. Its research and development efforts are directed towards treatments for neurodegenerative diseases, atherosclerosis, and non-alcoholic fatty liver disease. Additionally, the company utilizes stem cell models to explore disease-modifying effects, enabling patients to better manage and potentially alleviate the symptoms associated with these conditions.

Helaxy

Seed Round in 2022
Helaxy is a Singapore-based company established in 2020 that focuses on the development of fluidic cards designed for Next-Generation Sequencing (NGS) preparation solutions. The company aims to enhance laboratory efficiency by enabling clinicians to reduce manual pipetting errors while minimizing the wastage of reagents and plastic consumables. With its innovative technology, Helaxy seeks to streamline laboratory processes, thereby improving accuracy and efficiency in specialty laboratories.

Gravitics

Seed Round in 2022
Gravitics, Inc. specializes in the design and manufacturing of large space structures, including orbital carriers, cargo logistics spacecraft, and space station modules. The company is focused on developing aerospace station technology that serves as the foundation for human life in space. Utilizing next-generation hardware, Gravitics' innovations facilitate shipyard-style fabrication within the aerospace sector, providing clients with versatile interfacing options and robust space armor. Through its advancements, Gravitics aims to redefine space superiority and promote commercial development in Earth orbit and beyond.

HelixNano

Convertible Note in 2022
HelixNano is a biotechnology startup that employs artificial intelligence and synthetic biology to develop innovative treatments for genetic diseases. Founded with backing from Y Combinator and venture capitalists, the company initially focused on creating cancer vaccines over two years. Currently, HelixNano is adapting its technology to combat COVID-19, aiming to produce precise and safe vaccine candidates. Its long-term goal is to develop a universal coronavirus vaccine that protects against future outbreaks.

Orbem

Seed Round in 2022
Orbem is a company that specializes in a sensor-based artificial intelligence breeding monitoring system designed to transform food production systems. Utilizing advanced magnetic resonance imaging, Orbem's technology automatically analyzes and classifies biological samples, significantly enhancing food production methods to address the demands of a growing global population. The company’s solutions enable customers to optimize their processing lines, leading to increased cost efficiency and the creation of high-quality products, while also opening new revenue streams. By focusing on sustainability, Orbem aims to revolutionize the way food is produced, making it more efficient and environmentally friendly.

Radian

Seed Round in 2022
Radian Aerospace is innovating the aerospace sector with its next-generation spaceplane, which is the first fully reusable vehicle designed for horizontal takeoff and landing. This single-stage to orbit spacecraft aims to facilitate the transportation of people and light cargo to low Earth orbit as well as various terrestrial locations, operating in a manner similar to conventional aircraft. Radian's vehicles are constructed from advanced materials that can endure extreme conditions and are equipped with propulsion technologies that enhance maneuverability and overall performance. Additionally, they incorporate satellite systems that improve communication capabilities, thereby supporting enhanced missions and operational efficiency within the space industry.

Chingari

Series A in 2022
Chingari is a short-video entertainment platform that connects talented individuals across India. It enables users to create, share, and showcase their creativity through short videos, audio clips, GIF stickers, and photos. The platform is designed with various features, including video search, editing tools, and instant sharing options, allowing users to easily browse and publish their content on third-party social media platforms. Available for Android users, Chingari monetizes its services primarily through in-app advertisements, providing a space for users to express their talents while generating revenue for the company.

Epoch Biodesign

Seed Round in 2022
Epoch Biodesign is focused on creating natural solutions to address climate challenges through innovative biotechnological advancements. The company specializes in the development of plastic-eating enzymes that facilitate biorecycling, a tunable enzymatic process that converts plastic waste into everyday chemicals. By leveraging insights from nature alongside expertise in computational and biological sciences, Epoch Biodesign enables efficient recycling of unrecyclable plastic waste into low-carbon chemicals. Their approach emphasizes intelligent navigation of sequence space to discover and develop products utilizing complex proteins, thereby advancing sustainable practices in waste management.

Jefa

Seed Round in 2021
Jefa is a digital financial platform that aims to empower women by providing them with a comprehensive financial application. Initially launched in Mexico, Jefa's app offers users access to a financial marketplace, enabling them to manage their finances effectively. The application includes features such as an electronic payment account for sending and receiving money, automating service payments, and making purchases without hidden costs or commissions. Jefa focuses on delivering an affordable, convenient, and secure solution, ensuring that women have the tools they need to take control of their financial well-being.

Intellihealth

Seed Round in 2021
Intellihealth develops medical technology software to diagnose obesity-related diseases. The company's flagship product, Evolve, enables medical providers to offer effective medical obesity treatment to new and existing patients, both via telehealth and in person.

Altru

Pre Seed Round in 2021
Altru is a social platform designed to connect companies, nonprofit initiatives, and individuals, facilitating corporate giving that yields a positive return on investment. By enabling businesses to discover, fund, and promote social and environmental projects, Altru enhances community engagement and corporate social responsibility (CSR). The platform addresses the growing demand from consumers, particularly younger generations, for businesses to contribute to social causes and solve pressing issues. With a focus on creating meaningful connections among activist-creators, brands, and supporters, Altru positions itself as an essential tool for organizations seeking to align their operations with the values of a socially conscious populace. Thus, Altru not only promotes impactful initiatives but also demonstrates that corporate philanthropy can be strategically beneficial for businesses.

Elysium

Series C in 2021
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

SNAFU Records

Venture Round in 2021
SNAFU Records AB is a music company based in Stockholm, Sweden, founded in 2018. The company specializes in leveraging advanced algorithms to analyze data from major music platforms such as Spotify and YouTube. By scanning this vast array of information, SNAFU Records identifies emerging artists and standout songs, enabling it to discover and promote talent within the music industry.

HelixNano

Series A in 2021
HelixNano is a biotechnology startup that employs artificial intelligence and synthetic biology to develop innovative treatments for genetic diseases. Founded with backing from Y Combinator and venture capitalists, the company initially focused on creating cancer vaccines over two years. Currently, HelixNano is adapting its technology to combat COVID-19, aiming to produce precise and safe vaccine candidates. Its long-term goal is to develop a universal coronavirus vaccine that protects against future outbreaks.

GoalBased Investors

Seed Round in 2021
GoalBased Investors is a New York-based company founded in 2019 by Chip Castille, specializing in providing a social platform for goal-based financial planning and advice. The platform is designed to assist individuals in setting and achieving their financial goals, regardless of their level of financial literacy. By facilitating connections between users and financial advisors, the company enables clients to create, share, and refine financial plans collaboratively. Its streamlined approach enhances the user experience, incorporating elements that make financial planning more engaging and accessible. Through this innovative platform, GoalBased Investors aims to empower individuals to navigate their financial futures with confidence and clarity.

BettaF!sh

Seed Round in 2021
BettaF!sh is a manufacturing company established in 2020 and headquartered in Berlin, Germany, specializing in plant-based tuna alternatives. The company produces authentic-tasting vegan seafood using proteins derived from cultivated European seaweed, which is both regenerative and nutritious. By transforming seaweed into plant-based seafood, BettaF!sh aims to provide an eco-friendly alternative to traditional fish products, catering to consumers seeking sustainable food options.

BlockFi

Series D in 2021
BlockFi, Inc. is a financial services firm that specializes in providing wealth management products for cryptocurrency investors. Founded in 2017 and headquartered in New York, BlockFi offers various services, including interest-bearing accounts for Bitcoin, Ether, and Gemini Dollar, as well as USD loans secured by clients' crypto assets. The company allows clients to trade cryptocurrency pairs and provides tailored lending solutions for both individual and institutional clients. By facilitating liquidity for blockchain asset holders, BlockFi aims to enhance transparency and efficiency in digital financial markets. The organization employs a robust infrastructure that integrates with multiple blockchains, positioning itself to adapt and expand its product offerings in response to the evolving needs of its users.

Axiom Space

Series B in 2020
Axiom Space, Inc. is a Houston, Texas-based company founded in 2016 that focuses on developing and operating commercial space station modules connected to the International Space Station (ISS). The company offers human spaceflight services to government astronauts, tourists, and private enterprises, facilitating research, manufacturing, and testing of space exploration technologies. Axiom Space aims to provide universal access to the ISS, conducting missions for both national and private astronauts, and enabling clients from various sectors to engage in space initiatives. The company leverages its platform in Low Earth Orbit and extensive experience in human spaceflight management to create new opportunities for advanced industries and future space exploration endeavors.

Infogrid

Series A in 2020
Infogrid is an AI technology company that specializes in automating facilities management to create smarter buildings. By integrating Internet of Things (IoT) sensors with artificial intelligence, Infogrid streamlines and enhances building management processes, resulting in significant savings in time, costs, and environmental impact while also improving safety. The sensors used are compact, unobtrusive, and cost-effective, allowing for quick implementation. Infogrid's proprietary algorithms and machine learning capabilities convert collected data into actionable insights that promote energy efficiency and cost reduction, seamlessly integrating with existing systems. With its comprehensive platform, Infogrid enables clients to develop healthier, more sustainable, and profitable environments for their real estate and facilities teams.

Axiom Space

Series A in 2019
Axiom Space, Inc. is a Houston, Texas-based company founded in 2016 that focuses on developing and operating commercial space station modules connected to the International Space Station (ISS). The company offers human spaceflight services to government astronauts, tourists, and private enterprises, facilitating research, manufacturing, and testing of space exploration technologies. Axiom Space aims to provide universal access to the ISS, conducting missions for both national and private astronauts, and enabling clients from various sectors to engage in space initiatives. The company leverages its platform in Low Earth Orbit and extensive experience in human spaceflight management to create new opportunities for advanced industries and future space exploration endeavors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.